Fetzima (Levomilnacipran) Withdrawal Symptoms
Fetzima (Levomilnacipran), is a serotonin-norepinephrine reuptake inhibitor (SNRI) that was approved by the United States FDA in 2013 for the treatment of major depressive disorder. It was engineered to be a spinoff (or some might suggest an upgraded or slightly modified version) of the drug Savella (Milnacipran). Comparatively, Fetzima solely contains the levorotatory enantiomer of …